Advertisement

The Right to Not Know

Patients should be able to decline learning about incidental genetic findings when undergoing whole-genome screens, according to new expert recommendations.

By | April 2, 2014

NATIONAL INSTITUTES OF HEALTHPatients who have their genomes sequenced should be able to decide which results they’d like to know, the American College of Medical Genetics and Genomics (ACMG) announced yesterday (April 1). The organization’s new policy in effect reverses its controversial position on “incidental” genetic findings, announced last year, which many criticized. As the cost of genomic testing plunges, more tests are being done, and the likelihood that an unpleasant genetic surprise could be uncovered grows, posing a dilemma for clinicians.

The ACMG’s initial policy recommended that doctors tell patients about risks for genetic diseases even if those results were unrelated to why the test was ordered in the first place. In December, a federally appointed bioethics panel recommended patients should decide if they want to be alerted to unexpected genetic results.

ACMG now recommends that patients consult with their doctors to decide whether they want the tests done at all. “This update to our recommendations moves the opt-out discussion to the point where the sample is sent rather than at the time when results are received by the ordering clinician, as was originally recommended,” ACMG President Gail Herman said in a statement.

Some doctors oppose the new policy, however. “I worry that allowing this opt out will disproportionately impact the disenfranchised. It will become too easy for a lazy doctor just to say ‘OK, we’ll skip [this important testing],’” Robert Green of Harvard Medical School, who helped write the original ACMG recommendations, told Scientific American.

Advertisement
ASM
ASM

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: PastToTheFuture

PastToTheFuture

Posts: 65

April 2, 2014

This is completely irrelevant as in the future there will be reason (de novo mutations) to have a detailed knowledge of your genetics.

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Turning Tumor Cells Against Cancer
  3. Brazil’s Pre-Zika Microcephaly Cases
    The Nutshell Brazil’s Pre-Zika Microcephaly Cases

    A review of four years’ worth of medical records finds far greater numbers of microcephaly cases from before the ongoing Zika virus epidemic than had been officially reported.

  4. Aging Shrinks Chromosomes
Advertisement
Advertisement
Life Technologies